2019
DOI: 10.1007/978-3-030-01881-8_1
|View full text |Cite
|
Sign up to set email alerts
|

Advances in Drug Delivery Strategies for Microbial Healthcare Products

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 158 publications
0
1
0
Order By: Relevance
“…So, the growing demand for paclitaxel greatly exceeds the supply that can be sustained by these methods. Currently, recent studies considered paclitaxel as a drug with microbial origin (Ageitos and Garcia‐Fuentes ). More than 50 fungal strains that produce paclitaxel were reported by researchers from all over the world (Ismaiel et al ).…”
Section: Introductionmentioning
confidence: 99%
“…So, the growing demand for paclitaxel greatly exceeds the supply that can be sustained by these methods. Currently, recent studies considered paclitaxel as a drug with microbial origin (Ageitos and Garcia‐Fuentes ). More than 50 fungal strains that produce paclitaxel were reported by researchers from all over the world (Ismaiel et al ).…”
Section: Introductionmentioning
confidence: 99%